BDBM235340 (3aR,5R,6aS)-5-benzyl-2- ((R)-2-hydroxy-2-(4- hydroxyphenyl)ethyl)octa- hydrocyclopenta[c]pyrrol- 5-ol::US10052306, 136::US10052306, 142

SMILES O[C@@H](CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc(O)cc1

InChI Key InChIKey=PFQYYQCYAUKHMU-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 235340   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM235340(US10052306, 142 | (3aR,5R,6aS)-5-benzyl-2- ((R)-2-...)
Affinity DataIC50: 23.7nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM235340(US10052306, 142 | (3aR,5R,6aS)-5-benzyl-2- ((R)-2-...)
Affinity DataIC50: 23.7nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
Go to US Patent